FDA Silicone Breast Implant Review Moves Forward, Despite CoI Objections
This article was originally published in The Gray Sheet
Executive Summary
Michael Miller's contributions to the FDA General & Plastic Surgery Devices Panel's recent silicone-filled breast implant review outweigh any alleged conflict of interest, the agency maintains
You may also be interested in...
Seven Voting Members, Chair Revisit Silicone Implant Panel
Previous silicone implant panelist Michael Miller, MD, will return to the General & Plastic Surgery Devices Panel April 11-13 to evaluate Inamed's and Mentor's premarket approval applications, despite conflict of interest allegations in 2003
Seven Voting Members, Chair Revisit Silicone Implant Panel
Previous silicone implant panelist Michael Miller, MD, will return to the General & Plastic Surgery Devices Panel April 11-13 to evaluate Inamed's and Mentor's premarket approval applications, despite conflict of interest allegations in 2003
FDA CoI Policies For Advisory Committees Viewed As Fair, Credible – Study
Advisory committee members and meeting attendees perceive FDA's management of real or potential conflicts of interest among committee members as generally fair and credible, a 1study funded by the Joint Institute for Food Safety & Applied Nutrition says